ShEEP Request for Vevo 3100 Imaging System

ShEEP 请求 Vevo 3100 成像系统

基本信息

  • 批准号:
    9213727
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-01 至 2016-09-30
  • 项目状态:
    已结题

项目摘要

Medical ultrasound techniques are widely used for pre-clinical investigations. These non-invasive imaging modalities are crucial for researchers to observe changes in organ/tissue structure, size, and blood flow during disease stages as well as in response to pharmacological interventions. The requested equipment is an ultra high-frequency ultrasound machine (Vevo3100, FUJIFILM, VisualSonics) specifically manufactured to image mice, rats, and rabbits. The Vevo 3100 system will be equipped with a linear phased array ultrasound probe specific for animals in the size range of rabbits that is not currently available on our existing equipment. The Vevo 3100 system also has several upgrades in the ultrasound technology including; 1) improved resolution, 2) reduced artifact, 3) real time image processing, 4) left ventricular tracing, 5) improved workflow for rapid data acquisition, 6) speckle tracking analysis (for strain analysis), 7) an imaging station equipped with injection mount (for echo guided tissue injections), and 8) a high throughput analysis. All these functionalities would make this system a necessary part of our goal to produce high quality data in a time and cost efficient manner. Additionally, the Vevo 3100 system with high- resolution ultrasound has applications in nephrology by providing excellent delineation of renal tissues, the technology to quantify and analyze kidney size, and the ability to measure blood flow throughout the pelvic region. The functionality of this novel Vevo 3100 will allow our cardiovascular research groups (Drs. Roth, Patel, Dillmann, Hammond, Ross, and Mahata) as well as our colleagues in the nephrology department (Drs. Sharma, Singh, and Rajasekaran) the opportunities to expand their experimental capabilities.
医学超声技术广泛用于临床前调查。这些非侵入性

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID M ROTH其他文献

DAVID M ROTH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID M ROTH', 18)}}的其他基金

Exosomes in aging and operative hypothermic circulatory arrest
外泌体在衰老和手术低温停循环中的作用
  • 批准号:
    9766174
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure
整合素和小窝蛋白在心脏肥大和衰竭中的作用
  • 批准号:
    8535411
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure
整合素和小窝蛋白在心脏肥大和衰竭中的作用
  • 批准号:
    8726471
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure
整合素和小窝蛋白在心脏肥大和衰竭中的作用
  • 批准号:
    8842694
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure
整合素和小窝蛋白在心脏肥大和衰竭中的作用
  • 批准号:
    9061810
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.
通过 Caveolin 对肥大和心力衰竭中利尿钠肽的调节。
  • 批准号:
    8196337
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.
通过 Caveolin 对肥大和心力衰竭中利尿钠肽的调节。
  • 批准号:
    8597371
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Enhancing Cardiac Protection
加强心脏保护
  • 批准号:
    9339498
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.
通过 Caveolin 对肥大和心力衰竭中利尿钠肽的调节。
  • 批准号:
    8391592
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.
通过 Caveolin 对肥大和心力衰竭中利尿钠肽的调节。
  • 批准号:
    7931351
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:

相似海外基金

PREDICTING CARIES RISK IN UNDERSERVED CHILDREN, FROM TODDLERS TO THE SCHOOL-AGE YEARS, IN PRIMARY HEALTHCARE SETTINGS
预测初级医疗保健机构中从幼儿到学龄儿童的龋齿风险
  • 批准号:
    10361268
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    9751077
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    9976990
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    10457019
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    10213006
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了